Skip navigation
Agenda

Uniting Payers, Providers and Manufacturers to Increase Market Access and Identify Value Ecosystems for Mature and Emerging Oncologic Therapies

February 28-March 1, 2018
  • San Francisco, CA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, FEBRUARY 28, 2018

7:30

Registration and Continental Breakfast

8:30

Workshop Leader’s Welcome and Opening Remarks

8:45

IN-CONFERENCE WORKSHOP

Timeline Management for Product Launch — A Master Class

Workshop Objective:

As the marketplace makes room for new and diverse treatment options, it is more important than ever to have a well-developed timeline and clearly defined deliverables in preparation for a successful product launch. This master-class allows product teams to benchmark with their peers, collaborate with industry leaders and receive clear answers to the “what-if’s” that impact deadlines. The outcome of the workshop is a strategic product launch plan developed by the group.

Workshop Outline:

I. Preparing Product Launch Activities — The Who and the How

II. Preparing Product Launch Timelines — The When and the How

Workshop Leader:

Lesly Charanza
Vice President, Market Access – Oncology
Heron Therapeutics

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Main Conference Registration

1:15

Chairperson’s Welcome & Opening Remarks

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

1:30

OPENING KEYNOTE DISCUSSION Bridge the Gap Between Discovery and Commercial Success

Saikat Nandi, MS, PhD
Business Development Consultant
New York State Center for Biotechnology

Adapt Product Commercialization Strategies
to a Dynamic Marketplace

2:15

Innovative Market Access Models for a Sustainable Global Economy

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

3:00

Networking and Refreshment Break

3:30

PANEL DISCUSSION Navigate the Constantly Shifting Market Access Landscape

MODERATOR:

Dawn Holcombe, MBA, FACMPE
ACHE Director
NAMCP Medical Directors Institute Oncology Council

PANELISTS:

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc.

Sheldon J. Rich
President
SJR Associates, LLC

Chris Mancill
Vice President, Reimbursement   Oncology
EMD Serono

4:15

Ensure Market Adoption by Understanding Payer Perspectives

Joe Fuhr
Professor Emeritus of Economics, Widener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

George Hiller
Founder, The Hiller Pharmacy Group;
Former Executive Director, Pharmacy Benefit Management,
Blue Cross and Blue Shield of Alabama

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, MARCH 1, 2018

7:30

Continental Breakfast

8:00

Chairperson’s Review of Day One

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

8:15

Analyze the Dynamic Impact of Effective Expert Engagement on
Product Launch

Susanne M. Radke
Consultant, Medical Affairs and Lifescience Strategy
Medical Innovation in Context LLC

Respond to Evolving Pricing and
Reimbursement Models

9:00

Understand How to Adapt Market Strategies for Emerging and
Existing Therapeutics to New Oncology Performance Models

Dawn Holcombe, MBA, FACMPE
ACHE Director
NAMCP Medical Directors Institute Oncology Council

9:45

Networking and Refreshment Break

10:15

Understand the Impact of Medicare and Medicaid Pricing on
Market Access

Joe Fuhr
Professor Emeritus of Economics, Widener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

11:00

PANEL DISCUSSION Develop Reimbursement Strategies that Anticipate the
Disruptive Potential of Next-Generation Therapies

MODERATOR:

Sheldon J. Rich
President
SJR Associates, LLC

PANELISTS:

Christopher Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc.

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

Scott Megaffin
President
Churchill Pharmaceuticals

Robert Popovian, PharmD, MS
Vice President, US Government Relationsm
Pfizer Inc

11:45

Develop Immuno-Oncology Market Strategies to Support Reimbursement

Elizabeth K. Brooks
Partner
BioMedical Insights, Inc.

Christopher Nicita
Partner
BioMedical Insights, Inc.

12:30

Networking Luncheon

Develop Strategies to Successfully
Gain Formulary Access

1:30

Demonstrate Product Value to Achieve Market Differentiation and Increase Access

Saikat Nandi, MS, PhD
Business Development Consultant
New York State Center for Biotechnology

2:15

Understand Access and the Evolution of Drug Formulary Development
and Management

Sheldon J. Rich
President
SJR Associates, LLC

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, FEBRUARY 28, 2018

7:30

Registration and Continental Breakfast

8:30

Workshop Leader’s Welcome and Opening Remarks

8:45

IN-CONFERENCE WORKSHOP

Timeline Management for Product Launch — A Master Class

Workshop Objective:

As the marketplace makes room for new and diverse treatment options, it is more important than ever to have a well-developed timeline and clearly defined deliverables in preparation for a successful product launch. This master-class allows product teams to benchmark with their peers, collaborate with industry leaders and receive clear answers to the “what-if’s” that impact deadlines. The outcome of the workshop is a strategic product launch plan developed by the group.

Workshop Outline:

I. Preparing Product Launch Activities — The Who and the How

II. Preparing Product Launch Timelines — The When and the How

Workshop Leader:

Lesly Charanza
Vice President, Market Access – Oncology
Heron Therapeutics

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Main Conference Registration

1:15

Chairperson’s Welcome & Opening Remarks

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

1:30

OPENING KEYNOTE DISCUSSION Bridge the Gap Between Discovery and Commercial Success

Saikat Nandi, MS, PhD
Business Development Consultant
New York State Center for Biotechnology

Adapt Product Commercialization Strategies
to a Dynamic Marketplace

2:15

Innovative Market Access Models for a Sustainable Global Economy

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

3:00

Networking and Refreshment Break

3:30

PANEL DISCUSSION Navigate the Constantly Shifting Market Access Landscape

MODERATOR:

Dawn Holcombe, MBA, FACMPE
ACHE Director
NAMCP Medical Directors Institute Oncology Council

PANELISTS:

Chris Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc.

Sheldon J. Rich
President
SJR Associates, LLC

Chris Mancill
Vice President, Reimbursement   Oncology
EMD Serono

4:15

Ensure Market Adoption by Understanding Payer Perspectives

Joe Fuhr
Professor Emeritus of Economics, Widener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

George Hiller
Founder, The Hiller Pharmacy Group;
Former Executive Director, Pharmacy Benefit Management,
Blue Cross and Blue Shield of Alabama

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, MARCH 1, 2018

7:30

Continental Breakfast

8:00

Chairperson’s Review of Day One

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

8:15

Analyze the Dynamic Impact of Effective Expert Engagement on
Product Launch

Susanne M. Radke
Consultant, Medical Affairs and Lifescience Strategy
Medical Innovation in Context LLC

Respond to Evolving Pricing and
Reimbursement Models

9:00

Understand How to Adapt Market Strategies for Emerging and
Existing Therapeutics to New Oncology Performance Models

Dawn Holcombe, MBA, FACMPE
ACHE Director
NAMCP Medical Directors Institute Oncology Council

9:45

Networking and Refreshment Break

10:15

Understand the Impact of Medicare and Medicaid Pricing on
Market Access

Joe Fuhr
Professor Emeritus of Economics, Widener University;
Adjunct Faculty, Thomas Jefferson University College of Population Health

11:00

PANEL DISCUSSION Develop Reimbursement Strategies that Anticipate the
Disruptive Potential of Next-Generation Therapies

MODERATOR:

Sheldon J. Rich
President
SJR Associates, LLC

PANELISTS:

Christopher Boneham
Executive Director, Managed Markets
Aralez Pharmaceuticals US Inc.

Erin A. Zagadailov
Associate Director, Global Pricing, Market Access, and Health Economics
Takeda

Scott Megaffin
President
Churchill Pharmaceuticals

Robert Popovian, PharmD, MS
Vice President, US Government Relationsm
Pfizer Inc

11:45

Develop Immuno-Oncology Market Strategies to Support Reimbursement

Elizabeth K. Brooks
Partner
BioMedical Insights, Inc.

Christopher Nicita
Partner
BioMedical Insights, Inc.

12:30

Networking Luncheon

Develop Strategies to Successfully
Gain Formulary Access

1:30

Demonstrate Product Value to Achieve Market Differentiation and Increase Access

Saikat Nandi, MS, PhD
Business Development Consultant
New York State Center for Biotechnology

2:15

Understand Access and the Evolution of Drug Formulary Development
and Management

Sheldon J. Rich
President
SJR Associates, LLC

3:00

Close of Conference